Bayer AG (BAYRY)

Other OTC - Other OTC Delayed Price. Currency in USD
100.02+0.31 (+0.31%)
As of 11:42 AM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close99.71
Bid0.00 x
Ask0.00 x
Day's Range99.44 - 100.55
52wk Range94.36 - 135.71
1y Target EstN/A
Market Cap82.73B
P/E Ratio (ttm)16.47
Avg Vol (3m)84,843
Dividend & Yield2.87 (2.85%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters4 hours ago

    Monsanto ally Novozymes sees opportunity, risk in Bayer merger

    Novozymes (NZYMb.CO), already grappling with the consequences of low oil and crop prices, is watching anxiously to see what Bayer's (BAYGn.DE) purchase of Monsanto (MON.N) will mean for the Danish group's ties with its key agricultural partner. Chief Executive Peder Holk Nielsen said in an interview that a merged Bayer-Monsanto could extend the market for the company's smart microbial crop-boosting products, known as inoculants, but added the union also brings uncertainties. Nielsen has not yet held any discussions with Bayer about the future of its strategic tie-up with Monsanto, the BioAg Alliance, but said he expected to do so before the takeover is completed.

  • Investopedia4 hours ago

    Monsanto Stock Upgraded at Goldman Sachs (MON, BAYRY)

    For a second straight day, Monsanto shares were upgraded by a prominent Wall Street firm.

  • MarketWatch20 hours ago

    Acceleron Pharma tabs Bayer exec as next CEO

    Acceleron Pharma Inc. announced Tuesday that founder John Knopf would step down as president and chief executive and be replaced by an executive from Bayer AG . Acceleron announced that Bayer's president ...